Streetbeat News

Stock Prices

PROV

Provident Financial Holdings (NASDAQ:PROV) reported Q2 earnings of $0.31 per share, surpassing the consensus estimate of $0.25 by 24%. However, the company experienced a 6.06% decrease in earnings compared to $0.33 per share from the same period last year. Quarterly sales were $9.65 million, falling short of the $10.00 million estimate by 3.51% and marking a 6.69% decrease from the previous year's sales of $10.34 million.

Portfolio Pulse from totan@benzinga.com

January 29, 2024 | 11:01 am

MRBK

Piper Sandler analyst Frank Schiraldi has downgraded Meridian (NASDAQ:MRBK) from Overweight to Neutral and reduced the price target from $14 to $13.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 11:00 am

AAPL

INTC

MSFT

NFLX

SPY

TSLA

TXN

The past week's earnings reports from companies like Tesla, Intel, and Texas Instruments were disappointing, affecting market sentiment. However, Netflix's strong performance provided some optimism. With 25% of S&P 500 companies having reported, 69% beat EPS estimates and 68% beat revenue estimates. The upcoming week is tech-heavy with earnings from Microsoft and Apple being highly anticipated, especially Microsoft's AI initiatives. FactSet expects six 'Mag 7' companies, excluding Tesla, to report a 53.7% year-over-year earnings growth for Q4. Energy sector earnings are also to be watched due to low crude oil prices. The SPDR S&P 500 ETF Trust (SPY) saw a slight premarket increase.

Portfolio Pulse from Shanthi Rexaline

January 29, 2024 | 10:51 am

BELFB

Needham analyst James Ricchiuti has maintained a Buy rating on Bel Fuse (NASDAQ:BELFB) and increased the price target from $70 to $77.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 10:50 am

ZIM

Jefferies analyst Omar Nokta upgraded ZIM Integrated Shipping (NYSE:ZIM) from Hold to Buy and increased the price target from $14 to $20.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 10:47 am

CCCC

JP Morgan analyst Eric Joseph has upgraded C4 Therapeutics (NASDAQ:CCCC) from Underweight to Neutral and set a price target of $6.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 10:45 am

EE

Excelerate Energy Inc (NYSE:EE) has signed a 15-year LNG sale and purchase agreement with QatarEnergy to supply up to one million tons per annum of LNG to Bangladesh starting January 2026. The deal involves deliveries to floating storage and regasification units in Bangladesh, with volumes starting at 0.85 MTPA in 2026 and 2027, increasing to one MTPA from 2028 to 2040. This agreement follows a similar deal made with Petrobangla in November for the same time period. Excelerate's Q4 and full year 2023 results are expected on February 28, 2024. EE shares saw a slight increase of 0.52% to close at $15.54 on Friday.

Portfolio Pulse from Lekha Gupta

January 29, 2024 | 10:40 am

DLTR

JP Morgan analyst Matthew Boss has upgraded Dollar Tree (NASDAQ:DLTR) from Neutral to Overweight and increased the price target from $122 to $157.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 10:36 am

DG

JP Morgan analyst Matthew Boss has maintained an Underweight rating on Dollar General (NYSE:DG) but increased the price target from $108 to $120. This adjustment reflects a revised valuation of the company's stock by the analyst.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 10:32 am

CL

Raymond James analyst Olivia Tong has upgraded Colgate-Palmolive (NYSE:CL) from Market Perform to Outperform and set a price target of $91.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 10:30 am